A Study to Assess the Drug Absorption Into the Blood After Administration of 3 Doses of AZD5718

Summary

This study will be conducted to evaluate the AZD5718 pharmacokinetic (PK) doses in order to determine exposure in a new dose range and compare with previous results. This study will include 14 subjects in a single site in United Kingdom. Each subject will be involved in the study for 6 to 7 weeks.

Timeline

Start

2019-09-20

Primary completion

2019-10-31

Completion

2019-10-31

Drugs

Indications